Document is current
Any future updates will be listed below
-
Authors
Lore, Sierra https://orcid.org/0009-0002-8446-8411
Poganik, Jesse R. https://orcid.org/0000-0003-3098-8550
Atala, Anthony
Church, George https://orcid.org/0000-0001-6232-9969
Gladyshev, Vadim N.
Scheibye-Knudsen, Morten https://orcid.org/0000-0002-6637-1280
Verdin, Eric https://orcid.org/0000-0003-3703-3183
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1U01AI180158-01, 1U01AI180158-01)
- License Information
-
More Information
Article History
Received: 21 October 2024
Accepted: 27 March 2025
First Online: 8 May 2025
Competing interests
: G.C. declares potential conflicts of interest related to companies involved in transplantation and aging, including eGenesis, Qihan, GC Therapeutics, Cellino, Rejuvenate Bio and Thymmune (further interests, outside of the scope of the current work, can be found in the ). A.A. declares a potential conflict of interest with Precise Bio, related to the bioprinting of human corneas. S.L., J.R.P., V.N.G., M.S.‑K. and E.V. have no competing interests.
